Why Intern at Vertex? Hear From Our Interns
We were curious what attracted so many great candidates to our program, so we asked them one simple question: Why Vertex?
Our labs and offices around the globe are buzzing with new talent this summer as more than 191 interns join our mission to bring transformative medicines to people with serious diseases. But these interns aren’t making copies or coffee runs; they’re a vital part of our innovation engine. From helping advance our gene editing research in collaboration with CRISPR Therapeutics, to creating a natural language processing system that accelerates the time it takes to search thousands of documents, some of our most fascinating projects are being driven by the brightest young minds in science.
More than 8,000 students applied for our program this year, making it the most competitive year to date. We were curious what attracted so many great candidates to our program, so we asked them one simple question: Why Vertex?
Hear From Our Interns
Tanvi Deshpande, Formulation, Boston
Pursuing a Ph.D. in Pharmaceutical Sciences at the University of Maryland, Baltimore
“When I interned last year, it was definitely the innovative science that brought me to Vertex. I came back again this summer because I saw the passion in every Vertexian to work towards a cure for a rare genetic disease. Not only that, but also the family-like atmosphere, collaborative work environment and helping each other grow personally and professionally, which made me want to work here and be a part of the team again!"
Michael Schwabe, Discovery Core, San Diego
Pursuing a Bachelor of Science in Biochemistry at the University of San Diego
“As a rising fourth year, I was looking for an opportunity to not only expand my skillset, but also make an impact; I found that at Vertex. Vertex's approach to developing and evaluating novel therapeutics, combined with a collaborative and outgoing community, inspires me to learn as much as possible every day.”
Denise Ragusa, Regulatory Affairs, London
Pursuing a Bachelor of Science in Biomedical Sciences at Brunel University London
“When I read the job description, I realized I would be doing valuable, "real-life" work for the company. But most importantly, I was impressed by the genuine appreciation for our ideas, our potential and our past experiences. It is recognizing the worth of the employees that makes the difference, I think.”
Lily Wilkinson, Molecular Pharmacology, Boston
Pursuing a Bachelor of Science in Human Developmental and Regenerative Biology at Harvard University
“I was drawn to Vertex by its commitment to fast-paced, reliable research. I knew I would be exposed to a vast array of technologies that enable scientists to streamline the research process. Aside from the technology, the people attracted me. Assimilating to the Vertex culture was easy because everyone was so welcoming and easily offered answers or advice.”
Jamesha Senatus, Meetings and Events Services, Boston
Pursuing a Bachelor's Degree at Wellesley College
"I started at Vertex last year as a high school intern where I spent my mornings running experiments in the Learning Lab and my afternoons in a job placement. My team did not treat me like I was in high school; they valued my opinion and asked for my thoughts on important projects. On top of all of this, they are more like a family than a team. As a result, I decided to come back to Vertex and work with the same team again as a college intern."
Kevin Shani, Preclinical Safety, Boston
Pursuing a Bachelor of Science in Bioengineering at Harvard University
“Coming from Albania, where the pharma industry is of a minuscule prominence compared to Boston, I have always wanted to experience the biotech and pharma world from a hands-on perspective. Currently studying Bioengineering at Harvard and previously working as a research intern at the Wyss Institute, I felt that being part of a company so heavily involved in cutting-edge research and dedicated to developing science for a greater cause, such as CF, would be an invaluable asset for any young researcher like myself. Vertex has been a great window into the industry and an opportunity to learn and grow academically and career-wise, from being surrounded by a community of like-minded scientists and colleagues.”
Nimita Patel, CF Patient Services, Boston
Pursuing a Masters in Business Administration at Boston University
“Along with the strong commitment to CF, the people that work at Vertex are why I chose to come here. Everyone is so welcoming and helpful towards interns, especially my manager! It really makes a difference when you know you can count on the people you work with to lead you in the right direction.”
Marisa Zellmer, Environmental Health and Safety, Boston
Pursuing a Masters in Environmental Health at Tufts University
“After looking through the Vertex website and talking to several employees, I could tell that Vertex focused on building a sense of community within the company. Sometimes it can be hard to find a place where people actually like their jobs, but I could tell that Vertex worked to make sure that people felt like they had a place and a purpose within the company.”
Carlos Carneiro, International Medical Affairs, London
Graduated with a Master’s in Pharmaceutical Sciences at the University of Porto, Portugal
"I was drawn to Vertex by the possibility of joining an exciting international team in a company with an outstanding commitment to patients, which is reflected on the incredible track of success and excellence delivering transformative medicines to people with a catastrophic disease. Moreover, the opportunity to contribute to real business solutions and communicate Vertex’s innovative science to medical and scientific stakeholders was exciting."
Eleonore Tham, Drug Metabolism & Pharmacokinetics, Boston
Pursuing a Ph.D. in Synthetic Biology at Massachusetts Institute of Technology
“As part of a course, I worked for three months on a project where I developed a strategy to fight lung bacterial infections in CF patients. I was very impressed by the science at Vertex, its story, and the deep commitment it took to get to its two approved medicines.”